Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45.5M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
5.29M
-
Shares change
-
+1.03M
-
Total reported value, excl. options
-
$9.75M
-
Value change
-
+$1.92M
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$1.84
Significant Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q2 2024
20 filings reported holding ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share as of Q2 2024.
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.29M shares
of 45.5M outstanding shares and own 11.63% of the company stock.
Largest 10 shareholders include Knoll Capital Management, LLC (3.88M shares), Schonfeld Strategic Advisors LLC (672K shares), Parkman Healthcare Partners LLC (402K shares), UBS Group AG (168K shares), RENAISSANCE TECHNOLOGIES LLC (57.6K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (28.9K shares), GEODE CAPITAL MANAGEMENT, LLC (17.6K shares), OSAIC HOLDINGS, INC. (16.8K shares), PNC Financial Services Group, Inc. (13K shares), and CIBC WORLD MARKET INC. (12.5K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.